| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |